N8 Medical said today it submitted an investigational device exemption application to the FDA for a first-in-human study of its CeraShield endotracheal tube. The Dublin, Ohio-based company’s CeraShield ETT is a ceragenin-coated ETT designed to prevent the growth of biofilms and reduce potential for infection for intubated patients. “We are looking forward to bringing our […]